Patricia Gómez

A <scp>RAD</scp> 51 assay feasible in routine tumor samples calls <scp>PARP</scp> inhibitor response beyond <scp>BRCA</scp> mutation

Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara et al. · EMBO Molecular Medicine · 2018 · 263 citations · Full text

Uncertainty analyses in fault trees and Bayesian networks using FORM/SORM methods

Enrique Castillo, José Marı́a Sarabia, Cristina Solares et al. · Reliability Engineering & System Safety · 1999 · 60 citations

Reliability Engineering, Engineering, Reliability Modelling +12

Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor

Kimberly Blackwell, Howard A. Burris, Patricia Gómez et al. · Breast Cancer Research and Treatment · 2015 · 37 citations

Pi3k Inhibitors, Oncology, Breast Oncology +10

Implication of breast cancer phenotype for patients with leptomeningeal carcinomatosis

Davis Y. Torrejon, Mafalda Oliveira, Javier Cortés et al. · The Breast · 2012 · 34 citations · Full text

Tail uncertainty analysis in complex systems

Enrique Castillo, Cristina Solares, Patricia Gómez · Artificial Intelligence · 1997 · 13 citations

Engineering, Uncertainty Quantification, Uncertainty Principle +6